Media Articles Related to Apokyn (Apomorphine)
Cancer Drug Shows Early Promise for Parkinson's Disease
Source: MedicineNet Dementia Specialty [2016.07.13]
Title: Cancer Drug Shows Early Promise for Parkinson's Disease
Category: Health News
Created: 7/12/2016 12:00:00 AM
Last Editorial Review: 7/13/2016 12:00:00 AM
Donated Blood Won't Transmit Alzheimer's, Parkinson's Disease
Source: MedicineNet Blood Transfusion Specialty [2016.06.28]
Title: Donated Blood Won't Transmit Alzheimer's, Parkinson's Disease
Category: Health News
Created: 6/27/2016 12:00:00 AM
Last Editorial Review: 6/28/2016 12:00:00 AM
Parkinson's Disease: Symptoms, Causes, Stages, and Treatment
Source: MedicineNet Tremor Specialty [2016.06.01]
Title: Parkinson's Disease: Symptoms, Causes, Stages, and Treatment
Created: 8/16/2011 6:25:00 PM
Last Editorial Review: 6/1/2016 12:00:00 AM
Transplanted nerve cells survive a quarter of a century in a Parkinson's disease patient
Source: Transplants / Organ Donations News From Medical News Today [2016.05.04]
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson's disease.
Parkinson's disease: New insights into a traveling protein
Source: CJD / vCJD / Mad Cow Disease News From Medical News Today [2016.01.05]
A laboratory study indicates that one of the main proteins involved in Parkinson's disease pathology does not behave as a 'prion' In Parkinson's disease, the protein "alpha-synuclein" aggregates...
Published Studies Related to Apokyn (Apomorphine)
Randomized, placebo-controlled trial of trimethobenzamide to control nausea and
vomiting during initiation and continued treatment with subcutaneous apomorphine
may not be needed, although this has not been systematically studied... CONCLUSION: Our data suggest that trimethobenzamide helps reduce nausea/vomiting
Sustained efficacy of apomorphine in Japanese patients with advanced Parkinson's
apomorphine rescue treatment... CONCLUSIONS: Our results indicate that a 3-month use of intermittent apomorphine
Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. [2011.01]
Patients with Parkinson's disease (PD) frequently experience pain that could be in part due to central modification of nociception. In this randomized controlled double blind study, we compared the effect of apomorphine versus placebo on pain thresholds and pain-induced cerebral activity in 25 patients with PD...
Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations. [2009.05]
BACKGROUND: Motor fluctuations in patients with advanced Parkinson's disease may be successfully treated with subcutaneous apomorphine infusion or intraduodenal levodopa/carbidopa infusion. No comparative trials of these two alternatives were performed. AIMS OF THE STUDY: We present a subanalysis from a randomized crossover clinical trial where levodopa infusion as monotherapy was compared with any other combination of pharmacotherapy in fluctuating patients. Four patients used apomorphine infusion and oral levodopa in the comparator arm. The results of these four patients are presented in detail... CONCLUSIONS: Monotherapy with duodenal infusion of levodopa was more efficacious and brought greater QoL than combination therapy with apomorphine infusion in these fluctuating patients.
Apomorphine nodules in Parkinson's disease: best practice considerations. [2008.10]
Apomorphine hydrochloride infusion therapy is used by approximately 1000 people with advanced Parkinson's disease in the UK (Britannia Pharmaceuticals Ltd, 2008).
Clinical Trials Related to Apokyn (Apomorphine)
Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) [Completed]
Treatment of Apomorphine-induced Skin Reactions: a Pilot Study [Not yet recruiting]
Skin reactions as a result of continuous subcutaneous apomorphine infusion occur frequently
and interfere with the absorption of apomorphine. The histopathology of apomorphine-induced
skin reactions is poorly understood. Therefore treatment options are limited and suggestive.
Objective: to investigate the efficacy of four treatments including massage, dilution of
apomorphine, treatment with topical hydrocortisone and pre-treatment with subcutaneous
administered hydrocortisone, in Parkinson's disease patients with apomorphine-induced skin
Infusion of Apomorphine: Long-term Safety Study [Recruiting]
This is a Phase 3, multicenter, open-label, safety and efficacy study of continuous infusion
apomorphine in subjects with advanced Parkinson's Disease (PD) who are unable to achieve
adequate control despite optimized noninvasive therapy.
Safety/Efficacy of Tigan´┐Ż to Control Nausea/Vomiting Experienced During Apokyn´┐Ż Initiation and Treatment [Completed]
The purposes of the study are to determine:
i. To assess the efficacy of Tigan« (trimethobenzamide) in preventing nausea and vomiting
when initiating therapy with Apokyn« (apomorphine)
ii. To determine the optimal duration for continuation of Tigan« following initiation of
iii. To assess the safety of Tigan┬« in combination with Apokyn┬«
iv. To characterize the pharmacokinetic (PK) profile of apomorphine in subjects treated
concomitantly with and without Tigan┬«
Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO) [Recruiting]
OH dependence is associated with DA receptor changes. Both, the apomorphine test and the
D2Rec SPECt are usefull for monitoring DA receptor status. We aimed at studying whether DA
receptor hypofunction, assessed by means of the apomorphine test and the D2Rec SPECT, is a
marker of relapse in detoxified OH dependents patients.
Reports of Suspected Apokyn (Apomorphine) Side Effects
Condition Aggravated (2),
Atrial Fibrillation (2),
Malabsorption From Injection Site (2), more >>